Category: Clinical Breakthroughs
-
Investigating Quality of Life After Breast Reconstruction
Women who underwent autologous breast reconstruction following a mastectomy reported greater psychosocial and sexual well-being than those who chose implant-based reconstruction, according to a study published in the Journal of Clinical Oncology.
-
Race Ranks Higher Than Pounds in Diabetes, Heart-Health Risks
Americans of South Asian descent are twice as likely as whites to have risks for heart disease, stroke and diabetes, when their weight is in the normal range, according to a recent study.
-
Wearable Medical Device Improves Survival for Patients with Glioblastoma
Northwestern medicine scientist have shown how a medical device that delivers alternating electrical fields in addition to traditional chemotherapy can improve survival for patients with glioblastoma.
-
Thyroid Treatment in Pregnancy Does Not Improve Children’s IQ
Treating mild hypothyroidism during pregnancy does not lead to improved cognitive functioning in children through five years of age, according to a recent study in the New England Journal of Medicine.
-
Investigating the Impact of Testosterone Treatment on Older Men’s Health
Testosterone treatment in older men reduced anemia but did not improve cognitive function, and was associated with a significant increase in arterial plaque, according to Northwestern Medicine clinical trials.
-
Increasing Participation in Biobanking Research with Underrepresented Populations
A recent study assessed the barriers preventing individuals from participating in biobanking research projects, including concerns about informed consent and data sharing.
-
Mental Healthcare on Hand
With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
-
Using Stem Cells to Predict Toxicity of Chemotherapy Drugs
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
-
Comparing Implanted Devices for Advanced Heart Failure
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
-
Evaluating A Novel Chemo-free Combination Therapy for Lymphocytic Leukemia
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
